Extendicare (TSE:EXE) Given New C$13.50 Price Target at BMO Capital Markets

Extendicare (TSE:EXE - Get Free Report) had its price target hoisted by research analysts at BMO Capital Markets from C$11.00 to C$13.50 in a note issued to investors on Monday,BayStreet.CA reports. BMO Capital Markets' price objective indicates a potential upside of 3.77% from the company's previous close.

Several other research firms also recently weighed in on EXE. TD Securities upped their price target on Extendicare from C$9.50 to C$10.50 and gave the stock a "hold" rating in a research note on Thursday, November 14th. Royal Bank of Canada increased their target price on Extendicare from C$9.50 to C$11.00 and gave the stock a "sector perform" rating in a research note on Thursday, November 28th. Finally, Cormark raised Extendicare to a "moderate buy" rating in a research report on Wednesday, February 19th. Three research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat, Extendicare currently has an average rating of "Hold" and an average price target of C$11.50.

Extendicare Stock Down 0.5 %

TSE:EXE traded down C$0.07 during mid-day trading on Monday, hitting C$13.01. 184,127 shares of the company's stock were exchanged, compared to its average volume of 186,533. The company has a market cap of C$1.09 billion, a PE ratio of 16.59 and a beta of 1.26. The company has a debt-to-equity ratio of 283.02, a current ratio of 0.62 and a quick ratio of 0.98. Extendicare has a one year low of C$6.63 and a one year high of C$13.12. The business has a fifty day moving average price of C$10.84 and a 200 day moving average price of C$9.86.

Remove Ads

Extendicare Company Profile

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.